<DOC>
	<DOCNO>NCT01504984</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics equivalence safety compare pharmacokinetics characteristic SYO-1126 Glivec Film Coated tab 4T ( 400mg ) administer single-dose healthy male volunteer .</brief_summary>
	<brief_title>Crossover Study Compare Pharmacokinetic Property SYO-1126 Glivec Film Coated Tab Healthy Male Volunteers</brief_title>
	<detailed_description>Healthy volunteer administrate single-dose period I II ( crossover ) SYO-1126 Glivec Film Coated tab 4T ( 400mg ) imatinib 400mg . Every time medication , pharmacokinetic ( PK ) parameter safety SYO-1126 Glivec Film Coated tab 4T ( 400mg ) perform use blood sample conduct test ( vital sign , physical exam , ECG , laboratory test , etc . ) respectively .</detailed_description>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Between 20aged 45aged healthy male Over 55kg BMI : 18.5~25 kg/m2 Agreement write informed consent Subject symptoms acute disease time screen Clinically significant cardiovascular system , pulmonary system , renal system , endocrine system , blood system , gastrointestinal system , nervous system , mental disease malignant tumor Subject know gastrointestinal disease surgical history affect absorption drug An impossible one participate clinical trial result screen test Inadequate result laboratory test AST/ALT &gt; 1.5 x UNL Total bilirubin &gt; 1.5 X UNL Clinically significant allergic disease ( Except mild allergic rhinitis seem need medication ) Subject know hypersensitivity reaction imatinib analog Subject know history drug abuse show positive screening test Previously participate trial within 60 day Previously make whole blood donation within 60 day component blood donation within 30 day Previously blood transfusion within 30 day Not able take institutional standard meal Subject abnormal eating affect ADME drug Not able take grapefruitcontaining food Taking ETC ( ethical counter ) medicine include oriental medicine within 14 day take OTC ( counter ) medicine vitamin preparation within 7 day Continued take caffein ( caffein &gt; 5cup/day ) , drink ( alcohol &gt; 30g/day ) severe heavy smoker ( cigarette &gt; 1/2pack/day ) An impossible one participate clinical trial investigator 's decision include reason laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Evaluation pharmacokinetics equivalence</keyword>
	<keyword>Healthy volunteer</keyword>
	<keyword>Single dose period I II ( crossover )</keyword>
	<keyword>Healthy male volunteer</keyword>
</DOC>